Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
editorial
. 1997 Sep;73(863):529–530. doi: 10.1136/pgmj.73.863.529

The syndrome of motor restlessness--a treatable but under-recognised disorder.

A Bakheit
PMCID: PMC2431452  PMID: 9373589

Full text

PDF
529

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler L., Angrist B., Peselow E., Corwin J., Rotrosen J. Efficacy of propranolol in neuroleptic-induced akathesia. J Clin Psychopharmacol. 1985 Jun;5(3):164–166. [PubMed] [Google Scholar]
  2. Amsterdam J. D., Hornig-Rohan M., Maislin G. Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression. J Clin Psychiatry. 1994 Sep;55(9):394–400. [PubMed] [Google Scholar]
  3. Baldassano C. F., Truman C. J., Nierenberg A., Ghaemi S. N., Sachs G. S. Akathisia: a review and case report following paroxetine treatment. Compr Psychiatry. 1996 Mar-Apr;37(2):122–124. doi: 10.1016/s0010-440x(96)90572-6. [DOI] [PubMed] [Google Scholar]
  4. Brown K. W., Glen S. E., White T. Low serum iron status and akathisia. Lancet. 1987 May 30;1(8544):1234–1236. doi: 10.1016/s0140-6736(87)92687-0. [DOI] [PubMed] [Google Scholar]
  5. Carter C. J., Pycock C. J. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 1980 Jun 16;192(1):163–176. doi: 10.1016/0006-8993(80)91016-1. [DOI] [PubMed] [Google Scholar]
  6. Caspi N., Levine J. Treatment of resistant akathisia with ECT--a case report. Isr J Psychiatry Relat Sci. 1993;30(3):175–178. [PubMed] [Google Scholar]
  7. Drake R. E., Ehrlich J. Suicide attempts associated with akathisia. Am J Psychiatry. 1985 Apr;142(4):499–501. doi: 10.1176/ajp.142.4.499. [DOI] [PubMed] [Google Scholar]
  8. Ford B., Greene P., Fahn S. Oral and genital tardive pain syndromes. Neurology. 1994 Nov;44(11):2115–2119. doi: 10.1212/wnl.44.11.2115. [DOI] [PubMed] [Google Scholar]
  9. Gold R., Lenox R. H. Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence. J Clin Psychiatry. 1995 Oct;56(10):476–483. [PubMed] [Google Scholar]
  10. Goswami U., Channabasavanna S. M. Is akathisia a forerunner of tardive dyskinesia? A clinical report with brief review of literature. Clin Neurol Neurosurg. 1984;86(2):107–110. doi: 10.1016/0303-8467(84)90074-x. [DOI] [PubMed] [Google Scholar]
  11. Hamilton M. S., Opler L. A. Akathisia, suicidality, and fluoxetine. J Clin Psychiatry. 1992 Nov;53(11):401–406. [PubMed] [Google Scholar]
  12. Krajnik M., Zylicz Z. Terminal restlessness and nicotine withdrawal. Lancet. 1995 Oct 14;346(8981):1044–1044. doi: 10.1016/s0140-6736(95)91729-2. [DOI] [PubMed] [Google Scholar]
  13. Leo R. J. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry. 1996 Oct;57(10):449–454. doi: 10.4088/jcp.v57n1002. [DOI] [PubMed] [Google Scholar]
  14. McParland P., Pearce J. M. Restless legs syndrome in pregnancy. Case reports. Clin Exp Obstet Gynecol. 1990;17(1):5–6. [PubMed] [Google Scholar]
  15. Owens D. G. Extrapyramidal side effects and tolerability of risperidone: a review. J Clin Psychiatry. 1994 May;55 (Suppl):29–35. [PubMed] [Google Scholar]
  16. Poyurovsky M., Kosov A., Halperin E., Enoch D., Schneidman M., Weizman A. Akathisia-like behavior following ECT, and its successful treatment with low-dose mianserin. Int Clin Psychopharmacol. 1995 Nov;10(4):257–260. doi: 10.1097/00004850-199511000-00008. [DOI] [PubMed] [Google Scholar]
  17. Poyurovsky M., Kreinin A., Modai I., Weizman A. Lithium-induced akathisia responds to low-dose mianserin: case report. Int Clin Psychopharmacol. 1995 Nov;10(4):261–263. doi: 10.1097/00004850-199511000-00009. [DOI] [PubMed] [Google Scholar]
  18. Roehrs T., Zorick F., Sicklesteel J., Wittig R., Roth T. Age-related sleep-wake disorders at a sleep disorder center. J Am Geriatr Soc. 1983 Jun;31(6):364–370. doi: 10.1111/j.1532-5415.1983.tb05748.x. [DOI] [PubMed] [Google Scholar]
  19. Sachdev P. Iron and akathisia. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1221–1222. doi: 10.1136/jnnp.55.12.1221-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sachdev P. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias. Schizophr Bull. 1995;21(3):451–461. doi: 10.1093/schbul/21.3.451. [DOI] [PubMed] [Google Scholar]
  21. Saller C. F., Czupryna M. J., Salama A. I. 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade. J Pharmacol Exp Ther. 1990 Jun;253(3):1162–1170. [PubMed] [Google Scholar]
  22. Stewart J. T. Akathisia following traumatic brain injury: treatment with bromocriptine. J Neurol Neurosurg Psychiatry. 1989 Oct;52(10):1200–1201. doi: 10.1136/jnnp.52.10.1200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stoll A. L., Mayer P. V., Kolbrener M., Goldstein E., Suplit B., Lucier J., Cohen B. M., Tohen M. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry. 1994 Nov;151(11):1642–1645. doi: 10.1176/ajp.151.11.1642. [DOI] [PubMed] [Google Scholar]
  24. Walters A. S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995 Sep;10(5):634–642. doi: 10.1002/mds.870100517. [DOI] [PubMed] [Google Scholar]
  25. Weiss D., Aizenberg D., Hermesh H., Zemishlany Z., Munitz H., Radwan M., Weizman A. Cyproheptadine treatment in neuroleptic-induced akathisia. Br J Psychiatry. 1995 Oct;167(4):483–486. doi: 10.1192/bjp.167.4.483. [DOI] [PubMed] [Google Scholar]
  26. von Scheele C., Kempi V. Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up. Arch Neurol. 1990 Nov;47(11):1223–1224. doi: 10.1001/archneur.1990.00530110083021. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES